Study Shows Ushio’s Care222®Lamps Effectively Inactivate SARS-CoV-2 (The COVID-19 Virus)

Post date November 17, 2020

The first-ever research study conducted on the efficacy of far-UVC 222nm light against SARS-CoV-2 shows that just 3 mJ/cm2 of 222nm light effectively inactivated more than 99.7% of viable samples.

Be the first to hear about Christie CounterAct

Get updates on Christie CounterAct delivered directly to your inbox.

Yes, I consent to receive emails from Christie and its affiliates. I can opt-out at any time.

By submitting this form you acknowledge that you have read, understood and agree to our Terms and Conditions and Privacy Policy.